Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/8461

Title: Leukemia inhibitory factor is immunomodulatory
Authors: Hendriks, Jerome J. A.
Slaets, Leen
Carmans, Sofie
de Vries, E.
Dijkstra, C.
Stinissen, Piet
Hellings, Niels
Issue Date: 2008
Citation: JOURNAL OF NEUROIMMUNOLOGY, 197(2). p. 163-163
Abstract: Leukemia inhibitory factor (LIF) is produced by infiltrating immune cells and glial cells during auto-immune and injury responses in the central nervous system (CNS). During these responses, LIF promotes survival of glial cells and neurons. While various studies indicate that LIF also modulates ongoing inflammatory responses in vivo, data on underlying events are lacking. In this study we demonstrate that LIF modulates macrophage function by inhibiting the production of oxygen radicals and TNF-α, both potent mediators of CNS injury in neuroinflammatory diseases such as multiple sclerosis. These immunomodulatory effects of LIF on macrophages are accompanied by activation of the JAK/STAT3 signalling pathway, without affecting AKT and ERK activation. We furthermore show that LIF plays a role in myelin phagocytosis as it stimulates myelin uptake by macrophages. These results demonstrate that LIF has anti-inflammatory properties and enhances myelin clearance, implicating it is an important factor in inflammatory diseases of the CNS.
Publication appears at doi: 10.1016/j.jneuroim.2008.04.005
Notes: Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium. Transnatl Univ Limburg, Sch Life Sci, Diepenbeek, Belgium.
URI: http://hdl.handle.net/1942/8461
ISI #: 000258388700032
ISSN: 0165-5728
Category: M
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
Published version53.11 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.